image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates

Microlise

March 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SAAS
  • Price:
  • 111p
I caught up with CEO Nadeem Raza following Microlise’s FY24 update. The year was marked by international growth with new direct customers secured including WooliesX in Australia, GSF in the UK and Foodstuffs South Island in New Zealand. This was supported by the growth of new customers and the upsell of more products to existing customers in the UK, driving leverage of its tech stack. Microlise expects to deliver sales +13% to £81m (+6% organic), but the more important bit - recurring revenue from software sales - grew 21% to £54.7m, of which 11% was organic. There was a small hardware miss caused by a slowdown in OEM sales in H2, which is expected to return to normal levels, and also a supply chain bottleneck, which delaye ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

Related Articles

Mircrolise (September 2024)
Microlise (May 2024)
Microlise - ARR up 11% to £47.2m (February 2024)
Microlise - Interesting new issue (September 2021)

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMITED PERIOD OFFER!

SUBSCRIBE TODAY AND SAVE £30 WITH OFFER CODE 30OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW